Qian Zhicheng, Zhu Ling, Zhao Chunyang
Department of Ophthalmology, The People' Hospital, Jiangmen City, Guangdong Province 529000, China.
Yan Ke Xue Bao. 2002 Jun;18(2):99-101.
Observing and evaluating the clinical effects of panretinal photocoagulation with Argon laser for diabetic retinopathy.
According to the results of fundus fluorescence angiography (FFA), panretinal photocoagulation with Argon laser were performed on 143 eyes (87 cases) of diabetic retinopathy, including 79 eyes with preproliferative diabetic retinopathy eyes with proliferative diabetic retinopathy (PPDR), 64 (PDR). Examination about FFA, visual acuity and fundus condition were carried out before laser treatment and 3 months after photocoagulation. The regular following up lasted for 6 months to 2 years.
Laser photocoagulation proved effective in 122 eyes (85.31%) with diabetic retinopathy, including 73 eyes (92.41%) with PPDR, 49 eyes (76.56%) with PDR. The visual acuity were improved in 32 eyes (23.38%), no changes in 87 eyes (60. 84%), decrease in 24 eyes (16.78%). No complication was found in all patients.
Panretinal photocoagulation with Argon laser is a safe and effective method to control the condition of diabetic retinopathy.
观察和评估氩激光全视网膜光凝治疗糖尿病视网膜病变的临床效果。
根据眼底荧光血管造影(FFA)结果,对143只眼(87例)糖尿病视网膜病变患者行氩激光全视网膜光凝治疗,其中增殖前期糖尿病视网膜病变(PPDR)79只眼,增殖性糖尿病视网膜病变(PDR)64只眼。于激光治疗前及光凝治疗后3个月进行FFA、视力及眼底情况检查。定期随访6个月至2年。
激光光凝治疗糖尿病视网膜病变有效122只眼(85.31%),其中PPDR 73只眼(92.41%),PDR 49只眼(76.56%)。视力提高32只眼(23.38%),不变87只眼(60.84%),下降24只眼(16.78%)。所有患者均未发现并发症。
氩激光全视网膜光凝是控制糖尿病视网膜病变病情的一种安全有效的方法。